TITLE

Orbital sensor allows subject breathing room

AUTHOR(S)
Mortland, Shannon
PUB. DATE
May 2007
SOURCE
Crain's Cleveland Business;5/28/2007, Vol. 28 Issue 21, p3
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the development of electrocardiography sensor by the biotechnology firm Orbital Research Inc. in Cleveland, Ohio. The sensor was developed to detect astronauts and soldiers' heart rate through embedding it into a cotton t-shirt to be worn under a space suit or military fatigues. According to its lead research physiologist Aaron Rood, the product was approved by the U.S. Food and Drug Administration on December 2006.
ACCESSION #
25353062

 

Related Articles

  • CardioComm Solutions Inc. Receives FDA Clearance to Market First Over-the- Counter Heart Monitoring Solution.  // Biomedical Market Newsletter;1/21/2012, Vol. 21, p1 

    The article informs that CardioComm Solutions Inc. has received clearance from the U.S. Food & Drug Administration (FDA) for over-the-counter (OTC) sales and marketing of their consumer-based, hand-held heart rhythm monitor known as the HeartCheck Pen Handheld ECG. The FDA clearance also...

  • Two-man firm gets warning.  // Medical Device Daily;6/25/2008, Vol. 12 Issue 122, p3 

    The article reports on a warning letter posted on April 10, 2008 to Don Tay Industries in New Berlin, Wisconsin by the U.S. Food and Drug Administration for deviations from the quality systems regulations. The firm is said to be manufacturing Softy Trode disposable electrocardiogram electrodes....

  • FDA approved mobile ECG for iPhone.  // Cardiology Today;Jan2013, Vol. 16 Issue 1, p17 

    The article reports that AliveCor Inc. announced the approval by the U.S. Food and Drug Administration (FDA) of its iPhone-compatible mobile electrocardiography (ECG) in 2013, allowing physicians to remotely monitor the cardiovascular (CV) health of their patients.

  • HEALTH BULLETIN. Good, Brian // Men's Health;Jun2002, Vol. 17 Issue 5, p30 

    Presents various issues related to men's health. Effects of taking too many heartburn medications; Introduction of contact lens that can be worn up to a month; Information on the approval of the U.S. Food and Drug Administration of the first pocket-size electrocardiogram machine.

  • Disopyramide: Six Years' Experience. Wilson, Richard R.; Wallace, Andrew G. // Angiology;Jun1983, Vol. 34 Issue 6, p367 

    Since its approval by the FDA six years ago, oral disopyramide has earned a recognized role in the treatment of ventricular arrhythmias. During this time, clinical experience has refined our knowledge of this agent, allowing revision of dosing guidelines and better selection of patients. This...

  • Local company seeks approval for wireless medical device. Tinsley, Ben // Las Vegas Business Press (10712186);2/4/2008, Vol. 25 Issue 5, p5 

    The article reports on a device called NCIQ, which stands for noncontact cardiac output, developed by Noninvasive Medical Technologies of Las Vegas, Nevada to help first responders determine which patients need help faster than others. The NCIQ device measures, stores and transmits heart rates,...

  • Clinical pharmacokinetics of ranolazine. Jerling, Markus // Clinical Pharmacokinetics;2006, Vol. 45 Issue 5, p469 

    Ranolazine is a compound that is approved by the US FDA for the treatment of chronic angina pectoris in combination with amlodipine, β-adrenoceptor antagonists or nitrates, in patients who have not achieved an adequate response with other anti-anginals. The anti-anginal effect of ranolazine...

  • FDA approves nebivolol for hypertension treatment. Raible, Eric // Cardiology Today;Feb2008, Vol. 11 Issue 2, p9 

    The article reports that the U.S. Food and Drug Administration (FDA) has approved the premarket application of the beta-blocker nebivolol. According to the FDA, the drug maintained a safety and efficacy profile similar to that of approved hypertension drugs. Moreover, Nebivolol lowers blood...

  • FDA's MedWatch Safety Alerts: Feb 2010 Search Consumer Updates.  // Biomedical Market Newsletter;12/20/2010, p424 

    The article offers information on the reports received by the U.S. Food & Drug Administration (FDA), from health care professionals and patients. It states that the OneTouch SureStep Test Strips, used for measuring blood glucose levels of people suffering from diabetes, may provide false low...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics